Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) Shares Outstanding (Weighted Average) (2018 - 2025)

Avai Bio's Shares Outstanding (Weighted Average) history spans 7 years, with the latest figure at $86.5 million for Q1 2024.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 124.74% to $86.5 million in Q1 2024 year-over-year; TTM through Mar 2024 was $86.5 million, a 124.74% increase, with the full-year FY2024 number at $86.5 million, up 124.74% from a year prior.
  • Shares Outstanding (Weighted Average) hit $86.5 million in Q1 2024 for Avai Bio, up from $67.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for AVAI hit a ceiling of $86.5 million in Q1 2024 and a floor of $1.0 million in Q1 2020.
  • Historically, Shares Outstanding (Weighted Average) has averaged $39.1 million across 5 years, with a median of $29.3 million in 2022.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 79.71% in 2020 and later surged 2482.97% in 2021.
  • Tracing AVAI's Shares Outstanding (Weighted Average) over 5 years: stood at $26.3 million in 2020, then changed by 0.0% to $26.3 million in 2021, then grew by 22.64% to $32.2 million in 2022, then soared by 108.11% to $67.1 million in 2023, then increased by 29.0% to $86.5 million in 2024.
  • Business Quant data shows Shares Outstanding (Weighted Average) for AVAI at $86.5 million in Q1 2024, $67.1 million in Q4 2023, and $74.3 million in Q3 2023.